- ►hopkinsmedicine.org [PDF] SE Nissen, K Wolski - New England Journal of Medicine, 2007 - content.nejm.org From the Cleveland Clinic, Cleveland. Ad- dress reprint requests to Dr. Nissen
at the Department of Cardiovascular Medi- cine, Cleveland Clinic, 9500 Euclid
Ave., Cleveland, OH 44195, or at nissens@ccf. org. Cited by 1339 - Related articles - BL Direct - All 83 versions
- ►hopkinsmedicine.org [PDF] SE Kahn, SM Haffner, MA Heise, WH Herman, … - New England Journal of Medicine, 2006 - content.nejm.org From the Veterans Affairs Puget Sound Health Care System and University of
Washington, Seattle (SEK); University of Texas Health Science Center at San An
tonio, San Antonio (SMH); GlaxoSmith Kline, King of Prussia, PA (MAH, BGK, ... Cited by 781 - Related articles - BL Direct - All 30 versions
AJ Scheen, N Finer, P Hollander, MD Jensen, … - The Lancet, 2006 - Elsevier 1047 overweight or obese type 2 diabetes patients (body-mass index 27–40 kg/m
2 ) with a haemoglobin A 1c (HbA 1c ) concentration of 6·5–10·0% (mean 7·3%
[SD 0·9] at baseline) already on metformin or sulphonylurea monotherapy ... Cited by 287 - Related articles - All 12 versions
- Free from Publisher J Rosenstock, MA Baron, S Dejager, D Mills, … - Diabetes Care, 2007 - ncbi.nlm.nih.gov OBJECTIVE: To compare the efficacy and tolerability of vildagliptin and
rosiglitazone during a 24-week treatment in drug-naïve patients with type 2
diabetes. RESEARCH DESIGN AND METHODS: This was a double-blind, randomized, ... Cited by 145 - Related articles - BL Direct - All 5 versions
- ►pipex.com [PDF] RR Holman, KI Thorne, AJ Farmer, MJ Davies, … - New England Journal of Medicine, 2007 - content.nejm.org From the Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology, and
Metabolism (RRH, KIT, AJF, JFK, SP, JCL) and the Department of Primary Health
Care (AJF), University of Oxford, Oxford; and the Department of Cardiovas- ... Cited by 137 - Related articles - BL Direct - All 12 versions
J Rosenstock, MA Baron, R Camisasca, F … - Diabetes, Obesity and Metabolism, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 111 - Related articles - All 5 versions
- ►medicinainternacba.com.ar [PDF] EJ DeMaria - N Engl J Med, 2007 - journals.lww.com The percentage of adults who are obese or morbidly obese is increasing in the
United States and throughout the world, a trend that may lead to a decline in
overall life expectancy because of the link between obesity and increased ... Cited by 94 - Related articles - BL Direct - All 14 versions
- Free from Publisher DM Nathan, JB Buse, MB Davidson, E … - Diabetes Care, 2008 - ncbi.nlm.nih.gov 1: Diabetes Care. 2008 Jan;31(1):173-5. Management of hyperglycemia in
type 2 diabetes: a consensus algorithm for the initiation ... Cited by 97 - Related articles - All 2 versions
DM Nathan, J Kuenen, R Borg, H Zheng, D … - Diabetes Care, 2008 - Am Diabetes Assoc OBJECTIVE—The A1C assay, expressed as the percent of hemoglobin that is
glycated, measures chronic glycemia and is widely used to judge the adequacy of
diabetes treatment and adjust therapy. Day-to-day management is guided by ... Cited by 78 - Related articles - All 10 versions
A Barnett - International journal of clinical practice, 2006 - nerdoc.wordpress.com The dipeptidyl peptidase 4 (DPP-4) inhibitors enhance the body's own ability to
control blood glucose by increas- ing the active levels of incretin hormones in
the body. Their mechanism of action is distinct from any existing class of ... Cited by 69 - Related articles - View as HTML - BL Direct - All 7 versions
